SG156668A1 - Angiopoietin-2 specific binding agents - Google Patents

Angiopoietin-2 specific binding agents

Info

Publication number
SG156668A1
SG156668A1 SG200907008-7A SG2009070087A SG156668A1 SG 156668 A1 SG156668 A1 SG 156668A1 SG 2009070087 A SG2009070087 A SG 2009070087A SG 156668 A1 SG156668 A1 SG 156668A1
Authority
SG
Singapore
Prior art keywords
angiopoietin
specific binding
binding agents
antibodies
disclosed
Prior art date
Application number
SG200907008-7A
Other languages
English (en)
Inventor
Jonathon Daniel Oliner
Kevin Graham
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/982,440 external-priority patent/US7658924B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SG156668A1 publication Critical patent/SG156668A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG200907008-7A 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents SG156668A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62016104P 2004-10-19 2004-10-19
US10/982,440 US7658924B2 (en) 2001-10-11 2004-11-04 Angiopoietin-2 specific binding agents

Publications (1)

Publication Number Publication Date
SG156668A1 true SG156668A1 (en) 2009-11-26

Family

ID=39608222

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200907008-7A SG156668A1 (en) 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents

Country Status (10)

Country Link
JP (2) JP2008520188A (https=)
CN (1) CN101495513B (https=)
BR (1) BRPI0518209A (https=)
EA (1) EA011866B1 (https=)
IL (1) IL182279A0 (https=)
MA (1) MA29015B1 (https=)
MX (1) MX2007004247A (https=)
RU (2) RU2404992C2 (https=)
SG (1) SG156668A1 (https=)
ZA (1) ZA200704020B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0518209A (pt) * 2004-10-19 2008-11-04 Amgen Inc agentes de ligação especìficos à angiopoietina-2
JO3182B1 (ar) * 2009-07-29 2018-03-08 Regeneron Pharma مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
MY162940A (en) 2009-08-19 2017-07-31 Eisai R&D Man Co Ltd Quinoline derivative-containing pharmaceutical composition
EA022546B1 (ru) * 2011-09-28 2016-01-29 Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук Способ торможения роста карциномы эрлиха у лабораторного животного
HUE034044T2 (en) * 2011-09-30 2018-01-29 Dana Farber Cancer Inst Inc Therapeutic peptides
KR102063028B1 (ko) * 2012-01-23 2020-01-07 리제너론 파아마슈티컬스, 인크. 항-ａｎｇ2 항체를 함유하는 안정화된 제형
WO2014100834A1 (en) * 2012-12-21 2014-06-26 The Regents Of The University Of California Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
NZ714049A (en) * 2013-05-14 2020-05-29 Eisai R&D Man Co Ltd Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
AR100270A1 (es) * 2014-05-19 2016-09-21 Lilly Co Eli Anticuerpos ang2
PT3524595T (pt) 2014-08-28 2022-09-19 Eisai R&D Man Co Ltd Derivado de quinolina altamente puro e método para produção do mesmo
LT3263106T (lt) 2015-02-25 2024-01-10 Eisai R&D Management Co., Ltd. Chinolino darinių kartumo sumažinimo būdas
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
MX373231B (es) 2015-06-16 2020-05-08 Eisai R&D Man Co Ltd Agente anticancerigeno.
US12220398B2 (en) 2015-08-20 2025-02-11 Eisai R&D Management Co., Ltd. Tumor therapeutic agent
CN106075448A (zh) * 2016-07-25 2016-11-09 广州道瑞医药科技有限公司 Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用
CN106512006A (zh) * 2016-07-25 2017-03-22 广州道瑞医药科技有限公司 Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用
US12303505B2 (en) 2017-02-08 2025-05-20 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
RU2019134940A (ru) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Лечение гепатоцеллюлярной карциномы
CN109096368B (zh) * 2018-09-30 2021-07-20 华南理工大学 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用
US20220204603A1 (en) * 2019-02-25 2022-06-30 Pharmabcine Inc. Anti-ang2 antibody and use thereof
CN112126671B (zh) * 2020-08-18 2021-08-31 中山大学附属第五医院 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用
CN116265487B (zh) * 2021-12-16 2025-01-10 三优生物医药(上海)有限公司 抗ang2-vegf双特异性抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241380T1 (de) * 1999-03-26 2003-06-15 Regeneron Pharma Modulierung der gefässepermeabilität mittels tie2 rezeptoraktivatoren
US6342219B1 (en) * 1999-04-28 2002-01-29 Board Of Regents, The University Of Texas System Antibody compositions for selectively inhibiting VEGF
AU784231B2 (en) * 2000-06-23 2006-02-23 Schering Aktiengesellschaft Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use (II)
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
ATE536868T1 (de) * 2001-10-12 2011-12-15 Monosolrx Llc Einheitliche filme als schnell auflösende verabreichungsformen enthaltend geschmacksmaskiereden stoff
BRPI0518209A (pt) * 2004-10-19 2008-11-04 Amgen Inc agentes de ligação especìficos à angiopoietina-2

Also Published As

Publication number Publication date
MX2007004247A (es) 2007-06-12
EA011866B1 (ru) 2009-06-30
JP2011207882A (ja) 2011-10-20
CN101495513A (zh) 2009-07-29
ZA200704020B (en) 2008-06-25
CN101495513B (zh) 2014-08-06
IL182279A0 (en) 2007-07-24
MA29015B1 (fr) 2007-11-01
RU2010132956A (ru) 2012-02-10
RU2007118670A (ru) 2008-12-27
EA200700876A1 (ru) 2007-10-26
JP2008520188A (ja) 2008-06-19
BRPI0518209A (pt) 2008-11-04
RU2404992C2 (ru) 2010-11-27

Similar Documents

Publication Publication Date Title
WO2003030833A3 (en) Angiopoietin-2 specific binding agents
SG156668A1 (en) Angiopoietin-2 specific binding agents
MY156458A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
LUC00025I1 (https=)
SG166090A1 (en) Il-13 binding agents
WO2010017103A3 (en) Fully human anti-human nkg2d monoclonal antibodies
EA200400526A1 (ru) Агенты, специфически связывающиеся с человеческим ангиопоэтином-2
WO2012047583A3 (en) Antibodies binding human collagen ii
WO2010136311A3 (en) Compositions and methods for antibodies targeting complement protein c3b
PH12016501691A1 (en) Antibodies to matrix metalloproteinase 9
PH12016500658B1 (en) Human anti-alpha-synuclein autoantibodies
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
MY191348A (en) Antibodies and derivatives thereof
TW200635946A (en) Binding proteins specific for human matriptase
EP2192132A3 (en) Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
WO2006029220A3 (en) Combination therapy with anti-ctla4 and anti-4-1bb antibodies
WO2006116319A3 (en) Reagents that bind ccx-ckr2
WO2007076465A3 (en) Cln248 antibody compositions and methods of use
WO2006013462A3 (en) Growth factors nsg28, nsg30, and nsg32
TN2010000374A1 (en) Antibodies directed to angiopoietin -1 and angiopoietin-2 and use thereof
MX360580B (es) Autoanticuerpos humanos anti-alfa-sinucleina.